Research & Development
At Neutro Pharma, research is more than a department — it’s the foundation of everything we do. From the earliest stages of molecule design to the final stages of regulatory filing, our commitment to scientific precision, quality assurance, and international standards defines every product we develop. We blend cutting-edge research, advanced formulation techniques, and rigorous clinical validation to ensure our medicines and supplements meet the highest benchmarks of safety, efficacy, and accessibility across global markets.
Our Philosophy
At Neutro Pharma, we believe that the future of healthcare lies in continuous innovation. Our dedicated R&D division focuses on improving human health by discovering, developing, and optimizing medicines that meet global therapeutic needs.
Every new molecule, formulation, or delivery system we develop is guided by our mission to enhance quality of life while ensuring accessibility and affordability across diverse markets.
Facilities & Infrastructure
Our R&D facility includes modern formulation development labs, stability chambers, microbiological testing labs, and pilot-scale manufacturing suites. All infrastructure is built according to WHO-GMP and ICH guidelines, enabling smooth scale-up from lab bench to commercial production.
Dedicated departments include:
- Formulation Development
- Analytical R&D
- Microbiology Lab
- Clinical Trial Coordination
- Regulatory Affairs
Therapeutic Focus
Our research spans multiple therapeutic categories including:
- Oncology
- Cardiovascular
- Neurology & Psychiatry
- Infectious Diseases
- Dermatology & Cosmetology
- Orthopedics & Rheumatology
We constantly evaluate market needs and public health trends to ensure we are developing products that serve global demand with scientific relevance.
Innovation Beyond Borders
Neutro Pharma collaborates with Contract Research Organizations (CROs), international formulators, and academic institutions to foster joint development initiatives. We’re actively expanding our global R&D network across MENA, Southeast Asia, and Africa for accelerated innovation.
Our dossiers are compiled as per CTD/eCTD formats, and we actively participate in bioequivalence studies and technology transfer programs with global partners.
In-House Pilot Plant
Supports scale-up and process validation before full production roll-out.
State-of-the-Art Equipment
Equipped with HPLC, FTIR, UV Spectrophotometers, Dissolution Testers, and more.
Regulatory Compliance
All research meets DRAP, WHO, ICH, and EU regulatory protocols.
Global Formulation Filing
Developing export-ready dossiers for UAE, Iraq, Sri Lanka, and African markets.
Team of Experts
Led by PhDs, pharmacists, and formulation chemists with decades of combined experience.
Focus on Nutraceutical Innovation
Developing targeted multivitamins, immunity boosters, and metabolic health formulas.